Palmar plantar erythrodysesthesia risk factors: Difference between revisions
Jump to navigation
Jump to search
Mchitsazan (talk | contribs) No edit summary |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The most common and established risk factors are chemotherapeutic agents. The severity of the condition depends on the dose and frequency of the agent. | The most common and established [[Risk factor|risk factors]] are [[chemotherapeutic agents]]. The severity of the condition depends on the [[dose]] and frequency of the [[Chemotherapeutic agent|agent]]. | ||
==Risk Factors== | ==Risk Factors== | ||
Exposure to chemotherapeutic agents has been proven to be an established risk factor. | * Exposure to [[chemotherapeutic agents]] has been proven to be an established [[risk factor]]. | ||
* It has a direct relation with the [[dose]] of and duration of exposure to [[chemotherapeutic agents]]. | |||
* The [[data]] is limited to support any other associated [[risk factors]] as the [[pathophysiology]] of palmar plantar erythrodysesthesia. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 19:37, 5 August 2019
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia risk factors On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia risk factors |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
|
Risk calculators and risk factors for Palmar plantar erythrodysesthesia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
The most common and established risk factors are chemotherapeutic agents. The severity of the condition depends on the dose and frequency of the agent.
Risk Factors
- Exposure to chemotherapeutic agents has been proven to be an established risk factor.
- It has a direct relation with the dose of and duration of exposure to chemotherapeutic agents.
- The data is limited to support any other associated risk factors as the pathophysiology of palmar plantar erythrodysesthesia.